Giovanni Zagli1, Morena Cozzolino2, Alessandro Terreni3, Tiziana Biagioli3, Anna Lucia Caldini3, Adriano Peris2. 1. Anesthesia and Intensive Care Unit of the Emergency Department, Careggi University Hospital, Florence, Italy. Electronic address: giovanni.zagli@unifi.it. 2. Anesthesia and Intensive Care Unit of the Emergency Department, Careggi University Hospital, Florence, Italy. 3. Laboratory Department, Careggi University Hospital, Florence, Italy.
Abstract
BACKGROUND: To facilitate the clinical diagnosis of ventilator-associated pneumonia (VAP) in the ICU, the Clinical Pulmonary Infection Score (CPIS) has been proposed but has shown a low diagnostic performance in subsequent studies. We propose a new score based on procalcitonin level and chest echography with the aim of improving VAP diagnosis: the Chest Echography and Procalcitonin Pulmonary Infection Score (CEPPIS). METHODS: This retrospective pilot study recruited patients admitted to the Intensive Care Unit of the Emergency Department, Careggi University Hospital (Florence, Italy), from January 2009 to December 2011. Patients were retrospectively divided into a microbiologically confirmed VAP group or a control group based on diagnosis of VAP and positive tracheal aspirate culture. RESULTS: A total of 221 patients were included, with 113 in the microbiologically confirmed VAP group and 108 in the control group. A CEPPIS > 5 retrospectively fixed was significantly better in predicting VAP (OR, 23.78; sensitivity, 80.5%; specificity, 85.2%) than a CPIS > 6 (OR, 3.309; sensitivity, 39.8%; specificity, 83.3%). The receiver operating characteristic area under the curve analysis also showed a significantly higher diagnostic value for CEPPIS > 5 than CPIS > 6 (0.829 vs 0.616, respectively; P < .0001). CONCLUSIONS: In this pilot, exploratory analysis, CEPPIS is effective in predicting VAP. Prospective validation is needed to confirm the potential value of this score to facilitate VAP diagnosis.
BACKGROUND: To facilitate the clinical diagnosis of ventilator-associated pneumonia (VAP) in the ICU, the Clinical Pulmonary Infection Score (CPIS) has been proposed but has shown a low diagnostic performance in subsequent studies. We propose a new score based on procalcitonin level and chest echography with the aim of improving VAP diagnosis: the Chest Echography and Procalcitonin Pulmonary Infection Score (CEPPIS). METHODS: This retrospective pilot study recruited patients admitted to the Intensive Care Unit of the Emergency Department, Careggi University Hospital (Florence, Italy), from January 2009 to December 2011. Patients were retrospectively divided into a microbiologically confirmed VAP group or a control group based on diagnosis of VAP and positive tracheal aspirate culture. RESULTS: A total of 221 patients were included, with 113 in the microbiologically confirmed VAP group and 108 in the control group. A CEPPIS > 5 retrospectively fixed was significantly better in predicting VAP (OR, 23.78; sensitivity, 80.5%; specificity, 85.2%) than a CPIS > 6 (OR, 3.309; sensitivity, 39.8%; specificity, 83.3%). The receiver operating characteristic area under the curve analysis also showed a significantly higher diagnostic value for CEPPIS > 5 than CPIS > 6 (0.829 vs 0.616, respectively; P < .0001). CONCLUSIONS: In this pilot, exploratory analysis, CEPPIS is effective in predicting VAP. Prospective validation is needed to confirm the potential value of this score to facilitate VAP diagnosis.
Authors: Basem Al-Omari; Peter McMeekin; A Joy Allen; Ahsan R Akram; Sara Graziadio; Jana Suklan; William S Jones; B Clare Lendrem; Amanda Winter; Milo Cullinan; Joanne Gray; Kevin Dhaliwal; Timothy S Walsh; Thomas H Craven Journal: BMC Pulm Med Date: 2021-06-09 Impact factor: 3.317
Authors: Arif Hussain; Gabriele Via; Lawrence Melniker; Alberto Goffi; Guido Tavazzi; Luca Neri; Tomas Villen; Richard Hoppmann; Francesco Mojoli; Vicki Noble; Laurent Zieleskiewicz; Pablo Blanco; Irene W Y Ma; Mahathar Abd Wahab; Abdulmohsen Alsaawi; Majid Al Salamah; Martin Balik; Diego Barca; Karim Bendjelid; Belaid Bouhemad; Pablo Bravo-Figueroa; Raoul Breitkreutz; Juan Calderon; Jim Connolly; Roberto Copetti; Francesco Corradi; Anthony J Dean; André Denault; Deepak Govil; Carmela Graci; Young-Rock Ha; Laura Hurtado; Toru Kameda; Michael Lanspa; Christian B Laursen; Francis Lee; Rachel Liu; Massimiliano Meineri; Miguel Montorfano; Peiman Nazerian; Bret P Nelson; Aleksandar N Neskovic; Ramon Nogue; Adi Osman; José Pazeli; Elmo Pereira-Junior; Tomislav Petrovic; Emanuele Pivetta; Jan Poelaert; Susanna Price; Gregor Prosen; Shalim Rodriguez; Philippe Rola; Colin Royse; Yale Tung Chen; Mike Wells; Adrian Wong; Wang Xiaoting; Wang Zhen; Yaseen Arabi Journal: Crit Care Date: 2020-12-24 Impact factor: 9.097
Authors: Jean-Louis Vincent; Matteo Bassetti; Bruno François; George Karam; Jean Chastre; Antoni Torres; Jason A Roberts; Fabio S Taccone; Jordi Rello; Thierry Calandra; Daniel De Backer; Tobias Welte; Massimo Antonelli Journal: Crit Care Date: 2016-05-17 Impact factor: 9.097